Valuation Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. Other stock markets 16/06/2026			5-day change	1st Jan Change
1,565.00 ^ARS	-1.88%		-1.57%	-20.76%

11/05	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI
08/05	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	9,327	17,927	31,412	56,405	144,949	159,484
Change	-	92.21%	75.23%	79.56%	156.98%	10.03%
Enterprise Value (EV) ¹	10,516	22,242	50,309	149,735	278,596	390,519
Change	-	111.5%	126.19%	197.63%	86.06%	40.17%
P/E Ratio	19.2x	30.3x	193x	-5.2x	6.08x	51.6x
PBR	2.76x	3.39x	3.11x	2.5x	2.25x	1.74x
PEG	-	1.4x	-2.7x	0x	-0x	-0.6x
Capitalization / Revenue	1.51x	1.08x	1.7x	1.45x	1.58x	1.26x
EV / Revenue	1.7x	1.34x	2.72x	3.84x	3.04x	3.08x
EV / EBITDA	6.66x	8.95x	15.1x	23.2x	15.3x	11.8x
EV / EBIT	7.07x	9.58x	16.9x	28.3x	17.9x	13.1x
EV / FCF	-27.8x	-9.98x	-5.19x	58x	-49x	-7.4x
FCF Yield	-3.59%	-10%	-19.3%	1.72%	-2.04%	-13.5%
Dividend per Share ²	0.5547	-	-	-	26.89	-
Rate of return	0.48%	-	-	-	1.5%	-
EPS ²	6.02	7.32	2.02	-134.4	295.3	38.24
Distribution rate	9.21%	-	-	-	9.11%	-
Net sales ¹	6,181	16,616	18,470	39,028	91,794	126,726
EBITDA ¹	1,578	2,486	3,326	6,441	18,249	32,999
EBIT ¹	1,487	2,322	2,982	5,299	15,565	29,906
Net income ¹	486.2	591.5	163.4	-10,851	23,845	3,088
Net Debt ¹	1,189	4,315	18,897	93,330	133,647	231,035
Reference price ²	115.50	222.00	389.00	698.50	1,795.00	1,975.00
Nbr of stocks (in thousands)	80,751	80,751	80,751	80,751	80,751	80,751
Announcement Date	10/3/21	9/3/22	9/3/23	11/3/24	7/3/25	6/3/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIOS RICHMOND S.A.C.I.F.	-	-	-	-	88.16M
ELI LILLY AND COMPANY	32.85x	11.94x	24.59x	0.61%	1,001B
JOHNSON & JOHNSON	25.13x	5.79x	15.76x	2.27%	566B
ABBVIE INC.	27.6x	6.65x	13.6x	3.09%	393B
ROCHE HOLDING AG	17.38x	4.29x	10.55x	3.09%	326B
NOVARTIS AG	20.88x	5.41x	13.12x	2.97%	276B
ASTRAZENECA PLC	22.34x	4.67x	13.24x	1.87%	277B
NOVO NORDISK A/S	12.39x	4.65x	9.51x	4.05%	193B
AMGEN INC.	22.62x	6.06x	10.58x	2.9%	188B
GILEAD SCIENCES, INC.	-45.59x	5.5x	30.32x	2.55%	158B
Average	15.07x	6.11x	15.70x	2.6%	337.69B
Weighted average by Cap.	22.21x	7.38x	17.24x	2.13%